Our Annual Therapeutic Update is more than a conference - it's a community. It thrives on the collaborative spirit between pharmacists, healthcare leaders, and industry partners like you. Together, we provide a transformational experience that puts pharmacists at the forefront of clinical knowledge and practice.
Why Partner with the WA ATU?
-
Reach & Influence: Access to an audience of pharmacists, academics, and healthcare professionals who value quality, growth, and innovation
-
Thought Leadership: Position your organisation as an industry thought-leader through our education sponsorship opportunities
-
Networking: Forge meaningful relationships with professionals who are shaping the future of pharmacy in Australia
-
Visibility: Exceptional brand exposure through our extensive marketing and communications channels.
Sponsorship Opportunities
-
Exhibition Spaces: Showcase your solutions, products, or services directly to decision-makers and influencers.
-
Education Sessions: Sponsor clinical and practical workshops or masterclasses, shaping the content that educates the industry.
Ready to Make an Impact?
For more information on custom sponsorship packages or to initiate a partnership discussion, please reach out to us.
Email: partnerships@psa.org.au
Thanks to our WA ATU25 Partners
Camurus
treatment of drug dependence, endocrine disease, and cancer.
For more information visit; www.camurus.com.au/opioiddependence
GSK Vaccines
PDL
Pharmacists' Support Services
Prime Super
Whether your business is large or small, hands-on or highly automated, our dedicated team brings the experience and commitment needed to deliver a smooth and supportive superannuation journey for you and your employees. We go beyond simple transactions—our focus is on building lasting relationships, strengthening financial confidence, and deepening understanding of super.
As an independent, profit-to-member fund, your employees' best interests are always our priority.
With nearly 30 years of experience, Prime Super manages around $7.5 billion in retirement savings on behalf of 146,000 members across industries such as agriculture, horticulture, health, education, aged care, and recruitment.
Viatris
Viatris commenced Australian manufacture back in 1982 and now produces over 3 billion doses per annum from its Carole Park, Queensland site. Approximately 1 in 3 Viatris medicines supplied to Australian patients, are Australian made. In 2022 alone, we supplied high-quality medicines to approximately 1 billion patients around the world.
With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world’s most enduring health challenges, access takes on deep meaning at Viatris.
